According to the National Center for Vector Borne Disease Control (NCVBDC), Maharashtra recorded 2,726 malaria cases up to ...

Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which ...

Mumbai: As Maharashtra prepares for the upcoming monsoon season, health authorities are reporting a significant spike in chikungunya cases across the state. While malaria and dengue infections remain ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

In the wake of the rising cases of mosquito-borne illnesses and regular viral fever, health authorities urge the public to ...

Mumbai: Bandra West's upscale Pali Hill locality is reporting an unusual surge in chikungunya cases with at least 28 patients ...

French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...

Sri Lankan health officials have warned the public about the dangers of treating chikungunya without proper diagnosis, as it ...

VIMKUNYA is a single dose, prefilled, adjuvanted VLP recombinant protein vaccine for active immunization for the prevention ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...

The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...